India  

Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for human trials

IndiaTimes Monday, 29 June 2020 ()
0
shares
ShareTweetSavePostSend
 
Video credit: Oneindia - Published
News video: India bans 59 Chinese apps, PM Modi's address today and more news| Oneindia News

India bans 59 Chinese apps, PM Modi's address today and more news| Oneindia News 03:15

PM Narendra Modi will address the nation at 4 pm today, his 6th address to the nation since the outbreak of the pandemic; China is set to lose millions of app users in a growing, valuable Indian market; Rahul Gandhi takes dig at BJP, says 'Make in India = Buy from China; Indian and Chinese Corps...

💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Jagannath Rath Yatra attendees flout social distancing norms [Video]

Jagannath Rath Yatra attendees flout social distancing norms

In the ending ceremony of Jagannath Rath Yatra attendees were seen flouting social distancing norms amid increasing number of coronavirus infection cases. The annual, 13 days Jagannath Rath Yatra has ended with 'rasagulla' offers to goddess lakshmi by lord Jagannath on July 04. After denying it earlier, the Supreme Court has given permission to organise the annual Rath Yatra on June 22. As instructed, the procession has to be organised in a limited way without public attendance and only the servitors who have tested negative for COVID-19 can participate in the festival. Jagannath Rath Yatra is one of the auspicious festivals in India.

Credit: ANI    Duration: 01:39Published
Trump claims progress in fight against COVID-19 [Video]

Trump claims progress in fight against COVID-19

President Donald Trump said during July 4th celebrations in Washington D.C. Saturday that the U.S. has made a "lot of progress" in its fight against the pandemic even as two large states posted record increases in COVID-19 cases.

Credit: Reuters Studio    Duration: 00:38Published

Drug Controller General of India Drug Controller General of India organization

Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

After Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the..
IndiaTimes

You Might Like


Related videos from verified sources

Covid vaccine race| India puts 2 to human trials: Where do we stand? |Oneindia News [Video]

Covid vaccine race| India puts 2 to human trials: Where do we stand? |Oneindia News

India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to..

Credit: Oneindia     Duration: 01:30Published
Covid vaccine race| India puts 2 to human trials: Where do we stand? | Oneindia News [Video]

Covid vaccine race| India puts 2 to human trials: Where do we stand? | Oneindia News

India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to..

Credit: Oneindia     Duration: 02:34Published
Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine [Video]

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine

Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech company Moderna said the first phase of trials for a COVID-19 vaccine..

Credit: Wochit     Duration: 00:32Published

Related news from verified sources

Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

After Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the...
IndiaTimes

DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine

New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human...
Mid-Day


Tweets about this

KashmirPivot

Kashmir Pivot The first made-in-#India #coronavirus vaccine may be launched by August 15, with the Indian Council of Medical Rese… https://t.co/FSgDzG9RkB 37 seconds ago

takeonedigital

Take One Digital Network Drug Controller General of India gives approval to Hyderabad based Bharat Biotech for phase I & II human clinical t… https://t.co/E5ci3lrxtB 2 days ago

moneyguru_in

moneyguru With several pharma companies trying to develop a vaccine for #COVIDー19, Bharat Biotech’s #COVAXIN becomes the 1st… https://t.co/B4OYhvuZJM 2 days ago

is_souptik

Souptik Dirghangi RT @ANI: Drug Controller General of India gives approval to Hyderabad based Bharat Biotech for phase I & II human clinical trials of ‘Covax… 2 days ago

Sisirkumardatt3

Sisirkumardatta🇮🇳 RT @Sisirkumardatt3: Times of India: Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for hum… 2 days ago